ClinConnect ClinConnect Logo
Search / Trial NCT06680986

Echocardiographic Analysis by Artificial Intelligence in Hypertension

Launched by HOSPICES CIVILS DE LYON · Nov 7, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Hypertension Htn Arterial Hypertension Artificial Intelligence Ai Cardiac Remodelling Left Ventricular Hypertrophy

ClinConnect Summary

This clinical trial is studying how artificial intelligence (AI) can help us better understand heart changes in people with high blood pressure, also known as arterial hypertension. By analyzing routine heart imaging tests, called echocardiograms, along with patient information, the researchers aim to develop tools that can automatically measure and describe heart function more accurately. This could help doctors better track the progression of heart issues in patients, especially those whose conditions are not easy to categorize.

To participate in this study, individuals must be between the ages of 65 and 74 and have undergone a thorough blood pressure evaluation while hospitalized at specific cardiology clinics in Lyon, France, between 2018 and 2021. Unfortunately, younger individuals or those who are under guardianship cannot take part. If eligible, participants can expect to contribute to important research that may improve how we monitor and treat heart conditions related to high blood pressure. The trial is currently recruiting new participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria Patients who underwent a comprehensive blood pressure assessment during hospitalization in the Cardiologic Federation at Croix Rousse Hospital and Lyon Sud Hospital between January 2018 and December 2021.
  • Exclusion Criteria Patients who are minors. Patients under curatorship or guardianship.

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Pierre Bénite, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported